Navigation Links
Mylan Appoints Heather Bresch as Chief Operating Officer
Date:10/2/2007

Promoted from Head of North America

PITTSBURGH, Oct. 2 /PRNewswire-FirstCall/ -- Mylan Inc. (NYSE: MYL) today announced the appointment of Heather Bresch as Chief Operating Officer. Ms. Bresch served previously as Head of North America and Chief Integration Officer. As Chief Operation Officer, Ms. Bresch will be responsible for Mylan's global commercial and technical operations, strategic planning, business development and international affairs, which includes development of Mylan's antiretroviral (ARV) franchise. She will also continue to oversee the integration of Mylan's recent acquisition of Merck Generics.

Ms. Bresch has spent fifteen years with Mylan in various positions of increasing responsibility throughout the company. Most recently, as Head of North America, she had responsibility for Mylan's operations including Mylan Pharmaceuticals, Mylan Technologies, and UDL Laboratories. Prior to this, she served as Senior Vice President of Strategic Development in the Office of the CEO.

In her role as Chief Integration Officer, in addition to leading the integration team working with Merck Generics, Ms. Bresch has overseen the successful integration of Matrix Laboratories, in which Mylan took a controlling stake earlier this year.

Ms. Bresch has been the only non-CEO to serve as Chairman of the Generic Pharmaceutical Association (GPhA), serving an unprecedented two consecutive terms, and is widely acknowledged in the industry for playing a critical role in the passage of the 2003 Medicare Modernization Act, a Congressional revision to the Hatch-Waxman Act of 1984 that focused on ensuring consumers' access to affordable pharmaceuticals.

Mylan's Vice Chairman and CEO Robert J. Coury commented: "At this stage in Mylan's history, it is imperative that we have a Chief Operating Officer in place that knows our company, is a leader in the industry and has the experience and energy required to execute on the opportunities of the new Mylan. Heather is uniquely qualified for this challenging position, given her in-depth knowledge of Mylan, Matrix and Merck Generics and her strong relationships with management and employees across those organizations as a result of leading the integration efforts. She has played an instrumental role in Mylan's strategic development over the last several years, and will continue be a key driver of the Company's future success."

Ms. Bresch earned an MBA and an undergraduate degree in international studies and political science from West Virginia University.

Mylan Inc. is one of the world's leading quality generic and specialty pharmaceutical companies. The Company offers one of the industry's broadest and highest quality product portfolios, a robust product pipeline and a global commercial footprint through operations in more than 90 countries. Through its controlling interest in Matrix Laboratories Limited, Mylan has direct access to one of the largest active pharmaceutical ingredient (API) manufacturers in the world. Dey L.P., Mylan's fully integrated specialty business, provides the Company with innovative and diversified opportunities in the respiratory and allergy therapeutic areas.

For more information about Mylan, please visit http://www.mylan.com.


'/>"/>
SOURCE Mylan Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Mylan Wins Its Amlodipine Case With Pfizer
2. Mylan Announces Tentative FDA Approval for Its ANDA
3. Mylan Announces Final FDA Approval for Fluoxetine Capsules
4. Heather Mills Gives Cooker Demo on Veg Recipes
5. UNAIDS Chief Appeals for Projects to Battle AIDS/HIV
6. EU medical chief says Europe ready for bird flu
7. NHS acting chief’s intervie
8. Reminiscences of Chief Justice’s Call for Quality Medical Educatio
9. Joining The Military My Best Move - US Army Nursing Chief
10. Making Budhia run 65 km absolutely cruel,says Infosys chief
11. WHO Chiefs Sudden Death - A Major Loss To Global Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2018)... Minn. (PRWEB) , ... December 05, 2018 , ... A ... engaging, personalized fitness content to the masses. Wellbeats , which has delivered on-demand, ... released a new Wellbeats consumer app. Available now in the Apple App Store, ...
(Date:12/5/2018)... , ... December 05, 2018 , ... ... the causes of this condition are poorly understood. It manifests on the face, ... life threatening condition, it can cause enormous social and psychological problems. , Although ...
(Date:12/5/2018)... , ... December 04, 2018 , ... ... January 1st, 2019 at 16 E 4th Street. , The dispensary will serve ... Earthly Mist staff will work with patients to find the correct medical cannabis ...
(Date:11/29/2018)... ... November 29, 2018 , ... ... and released last month in the journal BMC Infectious Diseases published on ... are crawling with infectious viruses that can cause serious and in some ...
(Date:11/28/2018)... ... ... The awards keep coming in for RidgeCrest Herbals! Their Anxiety Free product ... in the past four years. This time, Anxiety Free earned the 2018 Remedies Magazine ... can have long-term health effects, which is why RidgeCrest Herbals offers Anxiety Free™. It ...
Breaking Medicine News(10 mins):
(Date:12/6/2018)... ... December 06, 2018 , ... Today, the ... answers for the millions of Americans and people worldwide who suffer first-hand with ... the renowned Alternative to Meds Center utilizes the tenets of neurochemistry in assessing ...
(Date:12/5/2018)... ... ... Trivellini Tech announces the latest version of Trivellini system and it ... Nano, Trivellini Long Hair introduces the ability to harvest long hair grafts during FUE ... capabilities as the last generation but it can also be programmed to extract long ...
(Date:12/5/2018)... ... 04, 2018 , ... Florida Hospital West Florida Division has ... the prestigious Leapfrog Group, a national nonprofit health care ratings organization, announced the ... Center Sebring, Florida Hospital Wesley Chapel and Florida Hospital Zephyrhills all received the ...
Breaking Medicine Technology: